-+ 0.00%
-+ 0.00%
-+ 0.00%

Onconetix subsidiary Proteomedix names co-founder Ralph Schiess to board

PUBT·08/05/2026 12:33:29
Listen to the news
Onconetix subsidiary Proteomedix names co-founder Ralph Schiess to board
  • Onconetix subsidiary Proteomedix appointed co-founder Ralph Schiess to its board.
  • Shareholders re-elected Thomas Meier as board chairman for a one-year term at the June 22 annual meeting.
  • Move adds Proclarix co-developer Schiess as Proteomedix advances its CE-IVD prostate cancer blood test.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608050830PRIMZONEFULLFEED9804104) on August 05, 2026, and is solely responsible for the information contained therein.